Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,327,000 | 14,565,000 | 18,169,000 | 8,007,000 | 8,629,000 |
| Marketable Securities | 375,000 | N/A | 45,000 | 615,000 | 599,000 |
| Receivables | 12,210,000 | 11,775,000 | 12,120,000 | 11,846,000 | 10,790,000 |
| Inventories | 6,479,000 | 6,658,000 | 6,444,000 | 6,601,000 | 6,196,000 |
| Other current assets | 10,624,000 | 10,518,000 | 10,779,000 | 9,996,000 | 9,289,000 |
| TOTAL | $35,015,000 | $43,516,000 | $47,557,000 | $37,065,000 | $35,503,000 |
| Non-Current Assets | |||||
| PPE Net | 25,433,000 | 25,316,000 | 25,639,000 | 25,236,000 | 24,793,000 |
| Investments And Advances | 1,105,000 | 956,000 | 1,117,000 | 774,000 | 616,000 |
| Intangibles | 47,326,000 | 48,260,000 | 36,900,000 | 36,784,000 | 37,442,000 |
| Other Non-Current Assets | 19,806,000 | 18,818,000 | 18,333,000 | 17,664,000 | 16,768,000 |
| TOTAL | $93,670,000 | $93,350,000 | $81,989,000 | $80,458,000 | $79,619,000 |
| Total Assets | $128,685,000 | $136,866,000 | $129,546,000 | $117,523,000 | $115,122,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,863,000 | 4,404,000 | 4,147,000 | 3,892,000 | 3,784,000 |
| Accrued Expenses | 14,549,000 | 14,468,000 | 16,186,000 | 14,502,000 | 12,772,000 |
| TOTAL | $26,945,000 | $28,327,000 | $28,628,000 | $26,037,000 | $25,174,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 46,673,000 | 46,750,000 | 39,969,000 | 33,968,000 | 33,484,000 |
| Other Non-Current Liabilities | 7,645,000 | 7,688,000 | 7,659,000 | 7,030,000 | 6,649,000 |
| TOTAL | $55,809,000 | $55,877,000 | $49,011,000 | $42,426,000 | $41,548,000 |
| Total Liabilities | $82,754,000 | $84,204,000 | $77,639,000 | $68,463,000 | $66,722,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,469,825 | 2,472,392 | 2,482,023 | 2,497,783 | 2,511,031 |
| Common Shares | 1,788,000 | 1,788,000 | 1,788,000 | 1,788,000 | 1,788,000 |
| Retained earnings | 66,721,000 | 73,075,000 | 72,231,000 | 68,477,000 | 66,097,000 |
| Other shareholders' equity | -4,007,000 | -4,231,000 | -5,145,000 | -5,354,000 | -4,900,000 |
| TOTAL | $45,931,000 | $52,662,000 | $51,907,000 | $49,060,000 | $48,400,000 |
| Total Liabilities And Equity | $128,685,000 | $136,866,000 | $129,546,000 | $117,523,000 | $115,122,000 |